By administering GSK’547, we aimed to evaluate the drugability of RIPK1 kinase in ApoE−/− Fbn1C1039G+/− mice, which is a unique model of advanced human-like atherosclerosis [27,28]. Here, APOE is linked to atherosclerosis.